The first face2face SeroSelectTB Consortium meeting was held 23-25 August 2022 in Cape Town. Due to Covid-related delays and travel restrictions, all previous meetings were digital.
The meeting included presentations from partners, a workshop addressing data collection, registration and randomization, and site visits to Wallacedene and Scottsdene health clinics where the study is conducted in South Africa.
Project partners also visited Lateral Flow Laboratories (LFL), our commercial partner responsible for SeroSelectTB test development and production. Meetings were also held between LFL and InVivo BioTech and E-MEDDIA to discuss antigen expression and regulatory procedures, respectively.
The value of face2face gatherings should never be underestimated! The meeting was very successful and most enjoyable!
Comments